LI Jiangwei,ZHANG Yanxue,PENG Jingxian,et al.Peng Qinghua's Experience in the Staged Treatment of Autoimmune Uveitis[J].Journal of Traditional Chinese Medicine,2023,64(23):2393-2396.
LI Jiangwei,ZHANG Yanxue,PENG Jingxian,et al.Peng Qinghua's Experience in the Staged Treatment of Autoimmune Uveitis[J].Journal of Traditional Chinese Medicine,2023,64(23):2393-2396.DOI: 10.13288/j.11-2166/r.2023.23.004.
Peng Qinghua's Experience in the Staged Treatment of Autoimmune Uveitis
This paper summarized clinical experience of Professor Peng Qinghua in the staged treatment of autoimmune uveitis (AU). The pathogenesis of AU is always based on root-cause deficiency and manifestation excess, with weakness of healthy
qi
as the root, and accumulation of wind, dampness and blood stasis as the minifestation. Syndrome differentiation and treatment is usually carried out according to different stages of disease. During the acute stage, deficiency of healthy
qi
and stagnation of wind-dampness are the key pathomechanisms, so the treatment is to replenish
qi
and activate blood, dispel wind and remove dampness, and self-made
Yiqi Huoxue Qufeng Chushi Decoction
(益气活血祛风除湿方) can be used. During remission stage, deficiency of spleen and kidney is the key mechanism, so the treatment is to tonify the spleen and kidney, replenish the essence and brighten the eyes, and self-made
Yijing Mingmu Decoction
(益精明目汤) can be used. Meanwhile, it was recommened to treat early, prevent and interrupt the disease, commonly combine with Chinese patent medicine
Zhengqing Fengtongning tablets
(正清风痛宁缓释片), and promote regulation of living to prevent recurrence.
关键词
Keywords
references
TSIROUKI T , DASTIRIDOU A , SYMEONIDIS C , et al . A focus on the epidemiology of uveitis [J]. Ocul Immunol Inflamm , 2018 , 26 ( 1 ): 2 - 16 .
GÓMEZ-GÓMEZ A , MADRID-GARCIA A , BORREGO-SANZ L , et al . Therapeutic response after immunosuppressive drug prescription in non-infectious uveitis:a survival analysisc [J]. Ophthalmol Ther , 2023 , 12 ( 1 ): 139 - 153 .
HUANG C , ZHANG Z , GU J , et al . Combined therapy of experimental autoimmune uveitis by a dual-drug nanocomposite formulation with berberine and dexamethasone [J]. Int J Nanomedicine , 2023 , 18 : 4347 - 4363 . doi: 10.2147/IJN.S417750 http://dx.doi.org/10.2147/IJN.S417750 .
WU X , TAO M , ZHU L , et al . Pathogenesis and current therapies for non-infectious uveitis [J]. Clin Exp Med , 2023 , 23 ( 4 ): 1089 - 1106 .
DEWISPELAERE R , LIPSKI D , FOUCART V , et al . ICAM-1 and VCAM-1 are differentially expressed on blood-retinal barrier cells during experimental autoimmune uveitis [J]. Exp Eye Res , 2015 , 137 : 94 - 102 . doi: 10.1016/j.exer.2015.06.017 http://dx.doi.org/10.1016/j.exer.2015.06.017 .